References
- Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin producing Clostridia. N Engl J Med 1978; 298: 531–4.
- Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet. 1978; 1: 1063.
- Bartlett JG. Antibiotic-associated colitis. Clinics in Gastroenterology. 1979; Vol 8, N° 3: 783.
- Bartlett JG, Chang TW, Taylor NS, Onderdonk AB. Colitis induced by Clostridium difficile. Rev Infect Dis. 1979; 1; 370–8.
- George WL, Sutter VL, Finegold SM. Toxicity and antimicrobial susceptibility of Clostridium difficile, a cause of antimicrobial agent associated colitis. Current Microbiol. 1978; 1: 55–8.
- Nord CE, Heimdahl A. Effect of phenoximethylpenicillin and clindamycin on the oral throat and fecal microflora of man. Scand J Infect Dis. 1979; 11: 233–42.
- George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol. 1979; 9: 214–9.
- Holdeman LV, Cato EP, Moore WE (ed.) Anaerobe Laboratory Manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg (1977).
- Bartlett JG. Experimental studies of antibiotic-associated colitis. Scand J Infect Dis. 1980; suppl. 22: 11–5.
- Bartlett JG, Chang TW, Moon N, Onderdonk AB. Antibiotic-induced enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin producing Clostridia. AM J Vet Res. 1978; 39: 1525–30.
- Ryan RW, Kwasnik I, Tilton RC. Rapid detection of Clostridium difficile toxin in human feces. J Clin Microbiol. 1980; 12: 776–9.
- Welch DF, Menge SK, Matsen JM. Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis. J Clin Microbiol. 1980; 11: 470–3.
- Tedesco FJ. Antibiotic-associated pseudomembranous colitis with negative proctosigmoidoscopy examination. Gastroenterology. 1979; 77: 295–7.
- Bartlett JG, Willey SH, Chang TW, Lowe B. Cephalosporin-associated pseudomembranous colitis due to Clostridium difficile. J Am Med Assoc. 1979; 242: 2683–5.
- Keighley MR, Burdon DW, Arabi Y et al. Randomized controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. Br. Med. J. 1978; 2: 1667–8.
- Tedesco FJ, Markam R, Gurwith M. Oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Lancet. 1978; 2: 226–8.
- Schapira AH, Dyson PH. Vancomycin dose for pseudomembranous colitis. Lancet. 1980; 2: 204.
- Bartlett JG, Tedesco FJ, Shull S, Lowe B, Chang TW. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology. 1980; 78: 431–4.
- Finch RG, McKim Thomas HJ, Lewis MJ, Slack RC, George RH. Relapse ol pseudomembranous colitis after vancomycin therapy. Lancet. 1979; 2: 1076.
- George WL, Volpicelli NA, Stiner DB et al Relapse of pseudomembranous colitis after vancomycin therapy. N Engl J Med. 1979; 301: 414.
- Kabins A, Spira JJ. Outbreak of clindamycin associated-colitis. Ann Int Med. 1975; 83: 830–1.
- Swarzberg JE, Maresca RM, Remington JS. Gastrointestinal side effects associated with clindamycin. Arch Int Med. 1976; 136: 876–9.
- Mulligan ME, Rolt’e RD, Finegold SM, George WL. Contamination of a hospital environment by Clostridium difficile. Current Microbiol. 1979; 3: 173–5.
- Dzink J, Bartlett JG. In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis. Antimicrob agents Chemother. 1980; 17: 695–8.